Robert R Maronpot Selected Research

Antioxidants

1/2022	Ameliorating effect of continuous alpha-glycosyl isoquercitrin treatment starting from late gestation in a rat autism model induced by postnatal injection of lipopolysaccharides.
1/2019	Ameliorating effect of postweaning exposure to antioxidant on disruption of hippocampal neurogenesis induced by developmental hypothyroidism in rats.
1/2018	Spironolactone in Combination with α-glycosyl Isoquercitrin Prevents Steatosis-related Early Hepatocarcinogenesis in Rats through the Observed NADPH Oxidase Modulation.
1/2006	Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants.
1/2003	Slowing tumorigenic progression in TRAMP mice and prostatic carcinoma cell lines using natural anti-oxidant from spinach, NAO--a comparative study of three anti-oxidants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert R Maronpot Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 03/2002
8	Inflammation (Inflammations) 01/2013 - 03/2002
7	Carcinogenesis 03/2008 - 07/2003
5	Body Weight (Weight, Body) 01/2022 - 09/2002
4	Carcinoma (Carcinomatosis) 01/2019 - 01/2003
3	Neuroinflammatory Diseases 01/2022 - 11/2008
3	Hyperplasia 01/2010 - 03/2002
3	Adenocarcinoma 01/2006 - 07/2003
3	Prostatic Neoplasms (Prostate Cancer) 01/2006 - 01/2003
3	Neoplasm Metastasis (Metastasis) 01/2005 - 01/2003
2	Hypothyroidism 07/2019 - 01/2019
2	Adenoma (Adenomas) 01/2019 - 07/2003
2	Hypertrophy 08/2010 - 01/2004
2	Alzheimer Disease (Alzheimer's Disease) 01/2010 - 09/2003
2	Hemangiosarcoma (Angiosarcoma) 03/2004 - 11/2002
1	Autism Spectrum Disorder 01/2022
1	Autistic Disorder (Autism) 01/2022
1	Insulin Resistance 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Obesity 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Necrosis 02/2016
1	Rotator Cuff Injuries 12/2015
1	Pathologic Processes 06/2013
1	Ulcer 01/2013
1	Infections 08/2010
1	Gliosis 11/2008
1	Hepatomegaly 06/2006
1	Intrahepatic Cholestasis 06/2006
1	Wounds and Injuries (Trauma) 01/2006

Drug/Important Bio-Agent (IBA)

5	AntioxidantsIBA 01/2022 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2003
4	DNA (Deoxyribonucleic Acid)IBA 03/2008 - 11/2002
3	isoquercitrinIBA 01/2022 - 01/2018
2	Biological ProductsIBA 01/2019 - 06/2013
2	Particulate MatterIBA 12/2010 - 11/2008
2	Air Pollutants (Pollutants, Air)IBA 02/2009 - 09/2003
2	Phenobarbital (Luminal)FDA Link 03/2007 - 10/2004
2	androstaneIBA 03/2007 - 10/2004
2	Orphan Nuclear ReceptorsIBA 03/2007 - 10/2004
2	10-N-nonylacridinium orange (NAO)IBA 01/2006 - 01/2003
2	CarcinogensIBA 10/2004 - 04/2004
2	Aflatoxin B1 (Aflatoxin B)IBA 04/2004 - 01/2003
2	vinyl carbamateIBA 04/2004 - 09/2002
2	BoronIBA 01/2004 - 01/2003
1	CytokinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Anti-Infective Agents (Microbicides)IBA 01/2022
1	Metronidazole (Metric)FDA LinkGeneric 01/2022
1	Thioctic Acid (Lipoic Acid)IBA 07/2019
1	Permethrin (Ambush)FDA LinkGeneric 01/2019
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2018
1	DiureticsIBA 01/2018
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	nasIBA 01/2018
1	LipidsIBA 01/2018
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2017
1	SolutionsIBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 02/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2016
1	caprolactoneIBA 12/2015
1	poly(lactide) (polylactic acid)IBA 12/2015
1	FlavonoidsIBA 01/2015
1	myricetinIBA 01/2015
1	myricitrinIBA 01/2015
1	Pharmaceutical PreparationsIBA 06/2013
1	gum ghattiIBA 01/2013
1	EndotoxinsIBA 12/2010
1	XenobioticsIBA 08/2010
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2010
1	PPAR alphaIBA 05/2010
1	thiamine triphosphorate (TTP)IBA 03/2010
1	Carrier Proteins (Binding Protein)IBA 03/2010
1	Messenger RNA (mRNA)IBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	LigandsIBA 02/2010
1	Apolipoproteins E (ApoE)IBA 01/2010
1	Amyloid beta-PeptidesIBA 01/2010
1	alpha-SynucleinIBA 01/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2009
1	Interferon-gamma (Interferon, gamma)IBA 02/2009
1	catalase-polyethylene glycolIBA 03/2008
1	Constitutive Androstane ReceptorIBA 03/2007
1	SmokeIBA 09/2006
1	Oral ContraceptivesIBA 06/2006
1	Estrogens (Estrogen)FDA Link 06/2006
1	Alkaline PhosphataseIBA 06/2006
1	Estradiol Congeners (Synthetic Estrogens)IBA 06/2006
1	Bile Acids and Salts (Bile Acids)IBA 06/2006
1	TEMPOIBA 01/2006
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2006

Therapy/Procedure

2	Therapeutics 06/2006 - 01/2005
1	Infusion Pumps (Infusion Pump) 01/2017